We identified the change in the response mechanism according to the genetic characteristics of cancer cells by observing changes in the intracellular signaling system after PEM treatment using various NSCLC cell lines, including cell lines with an EML4-ALK rearrangement. The gene discussed is EML4; the disease is non-small cell lung carcinoma.